Keywords: Bristol-Myers Squibb, ZymoGenetics, Novo Nordisk

Bristol-Myers Squibb buys ZymoGenetics for $855 million

Article | 08 September 2010

Print This

US drug major Bristol-Myers Squibb (NYSE:BMY) says it has signed an agreement to acquire ZymoGenetics (Nasdaq: ZGEN) for $9.75 per ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in